DCGO

DocGo Inc. [DCGO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DCGO Stock Summary

Top DCGO Correlated Resources

DCGO


Top 10 Correlated ETFs

DCGO


Top 10 Correlated Stocks

DCGO


In the News

07:35 08 Dec 2022 DCGO

DocGo to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President, will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City. Mr. Capone is scheduled to participate in one-on-one meetings with institutional analysts and investors throughout the day.

02:54 08 Dec 2022 DCGO

DocGo: Current Post-Earnings Sell-Off Presents Double-Digit Upside Potential

DocGo Q3 beat topline revenue but missed bottom-line earnings; however, that was due to accounting for a one-time loss from the remeasurement of warrant liabilities. The end of Covid Testing did not materially impact its revenue stream, while its long-term municipal contracts are looking to expand, serving as a recession cushion.

09:15 08 Dec 2022 DCGO

DocGo Announces Upcoming Participation in Four Investor Conferences

NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President will participate at the following four investor conferences during the month of November: Citi Consumer Dirsputive Growth Conference on Monday, November 14 at 8:30AM Eastern Time.

09:14 08 Dec 2022 DCGO

DocGo Inc. (DCGO) Q3 2022 Earnings Call Transcript

DocGo Inc. (NASDAQ:DCGO ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Mike Cole - Vice President, IR Stan Vashovsky - CEO, Co-Founder Andre Oberholzer - CFO Anthony Capone - President Conference Call Participants Matt Shae - Needham Sarah James - Barclays Richard Close - Canaccord Genuity Kieran Ryan - Deutsche Bank Mike Latimore - Northland Securities David Grossman - Stifel Operator Thank you for standing by. This is the conference operator.

04:35 08 Dec 2022 DCGO

DocGo to Announce Third Quarter 2022 Results on Monday, November 7

NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO) will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7.

07:35 08 Dec 2022 DCGO

DocGo Announces Upcoming Participation at LD Micro Investor Conference

NEW YORK--(BUSINESS WIRE)--DocGo's Vice President of Investor Relations, Michael Cole, to participate at LD Micro's The Main Event investor conference 10/25 at 11:00 AM ET.

11:17 08 Dec 2022 DCGO

Is Motion Acquisition (DCGO) Outperforming Other Medical Stocks This Year?

Here is how DocGo Inc. (DCGO) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.

09:23 08 Dec 2022 DCGO

3 IPO Stocks That You Want to Own

This down market is giving us some really intriguing stocks at cheap prices.

09:40 08 Dec 2022 DCGO

This Company Could Beat Out Teladoc, and It's Not Amazon

A potentially disruptive business model is finding its legs in the post-pandemic healthcare landscape.

04:00 08 Dec 2022 DCGO

DocGo: A Tech Story Wrapped In Telehealth And Last-Mile Care

Headquartered in NYC, DocGo provides innovative solutions to urban healthcare problems. The company has had a strong growth momentum since its IPO and is in a healthy financial condition.

DCGO Financial details

Company Rating
Buy
Market Cap
751.67M
Income
50.08M
Revenue
453.05M
Book val./share
2.67
Cash/share
1.71
Dividend
-
Dividend %
-
Employees
1.71K
Optionable
No
Shortable
Yes
Earnings
07 Nov 2022
P/E
13.82
Forward P/E
-
PEG
-0.34
P/S
1.48
P/B
2.54
P/C
3.89
P/FCF
29.72
Quick Ratio
3.51
Current Ratio
3.54
Debt / Equity
0.05
LT Debt / Equity
0.05
-
-
EPS (TTM)
0.44
EPS next Y
-
EPS next Q
-
EPS this Y
-309.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-4.75%
EPS Q/Q
-76.92%
-
-
-
-
SMA20
-12.5%
SMA50
-30%
SMA100
-
Inst Own
32.9%
Inst Trans
5.79%
ROA
14%
ROE
21%
ROC
0.13%
Gross Margin
36%
Oper. Margin
8%
Profit Margin
11%
Payout
-
Shs Outstand
102.83M
Shs Float
79.19M
-
-
-
-
Target Price
11
52W Range
4.96-11.41
52W High
-39.55%
52W Low
+66.25%
RSI
37
Rel Volume
0.35
Avg Volume
779.46K
Volume
272.49K
Perf Week
-9.52%
Perf Month
-29.85%
Perf Quarter
-14.52%
Perf Half Y
-19.59%
-
-
-
-
Beta
-
-
-
Volatility
0.27%, 1.06%
Prev Close
-1.77%
Price
6.65
Change
2.15%

DCGO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2020-12-31 2021-12-31
Revenue per share
0.943.97
Net income per share
-0.140.3
Operating cash flow per share
-0.11-0.02
Free cash flow per share
-0.17-0.11
Cash per share
0.322.19
Book value per share
0.552.73
Tangible book value per share
0.52.59
Share holders equity per share
0.552.73
Interest debt per share
0.140.2
Market cap
1.02B520.3M
Enterprise value
999.72M361.28M
P/E ratio
-70.9121.91
Price to sales ratio
10.821.63
POCF ratio
-95.57-267.18
PFCF ratio
-60-60.11
P/B Ratio
18.512.37
PTB ratio
18.512.37
EV to sales
10.631.13
Enterprise value over EBITDA
-112.4611.78
EV to operating cash flow
-93.83-185.52
EV to free cash flow
-58.91-41.74
Earnings yield
-0.010.05
Free cash flow yield
-0.02-0.02
Debt to equity
0.180.05
Debt to assets
0.330.27
Net debt to EBITDA
2.08-5.19
Current ratio
2.494.42
Interest coverage
72.12-20.13
Income quality
0.74-0.08
Dividend Yield
00
Payout ratio
00
Sales general and administrative to revenue
0.410.25
Research and developement to revenue
0.010.01
Intangibles to total assets
0.170.06
Capex to operating cash flow
0.593.44
Capex to revenue
-0.07-0.02
Capex to depreciation
-1.15-0.95
Stock based compensation to revenue
0.010
Graham number
1.334.27
ROIC
-0.190.06
Return on tangible assets
-0.170.08
Graham Net
0.181.89
Working capital
34.93M198.16M
Tangible asset value
49.66M207.69M
Net current asset value
25.2M173.49M
Invested capital
0.250.08
Average receivables
24.85M51.62M
Average payables
3.95M9.89M
Average inventory
00
Days sales outstanding
96.4289.77
Days payables outstanding
2327.66
Days of inventory on hand
00
Receivables turnover
3.794.07
Payables turnover
15.8713.2
Inventory turnover
00
ROE
-0.260.11
Capex per share
-0.06-0.08

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.861.211.181.11.05
Net income per share
0.030.240.110.130.03
Operating cash flow per share
0.08-0.090.180.120.07
Free cash flow per share
0.07-0.110.170.110.05
Cash per share
0.391.751.8821.71
Book value per share
0.562.192.322.492.67
Tangible book value per share
0.52.072.212.372.18
Share holders equity per share
0.562.192.322.492.67
Interest debt per share
0.230.160.160.150.21
Market cap
998.2M937.07M926.64M709.03M981.69M
Enterprise value
982.05M778.04M754.93M525.54M832.66M
P/E ratio
71.159.9421.7913.9277.8
Price to sales ratio
11.637.727.866.479.41
POCF ratio
124.8-106.4850.7359.47132.29
PFCF ratio
138.51-84.3354.163.87180.85
P/B Ratio
17.734.273.992.873.72
PTB ratio
17.734.273.992.873.72
EV to sales
11.446.416.44.87.98
Enterprise value over EBITDA
167.1331.357.4734.5992.48
EV to operating cash flow
122.78-88.4141.3344.08112.21
EV to free cash flow
136.27-70.0244.0847.34153.4
Earnings yield
00.030.010.020
Free cash flow yield
0.01-0.010.020.020.01
Debt to equity
0.180.050.040.040.05
Debt to assets
0.530.270.260.230.24
Net debt to EBITDA
-2.75-6.4-13.07-12.08-16.55
Current ratio
1.444.424.44.763.54
Interest coverage
-5.94-58.94-74.4475.8912.56
Income quality
2.28-0.371.720.942.35
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.240.240.210.250.23
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.120.060.060.060.16
Capex to operating cash flow
-0.10.26-0.06-0.07-0.27
Capex to revenue
-0.01-0.02-0.01-0.01-0.02
Capex to depreciation
-0.39-1.48-0.52-0.4-0.66
Stock based compensation to revenue
0.0100.010.020.01
Graham number
0.673.42.352.681.38
ROIC
0.020.060.040.030.01
Return on tangible assets
0.030.080.030.040.01
Graham Net
0.011.511.61.761.46
Working capital
29.77M198.16M207.18M217.74M180.85M
Tangible asset value
49.63M207.69M221M235.29M215.65M
Net current asset value
19.71M173.49M183.24M198.22M166.91M
Invested capital
0.420.080.070.060.08
Average receivables
61.88M75.32M74.21M72.25M76.13M
Average payables
13.15M14.37M14.02M12.92M12.53M
Average inventory
00000
Days sales outstanding
53.9958.1558.1559.3869.02
Days payables outstanding
20.0619.8217.4516.5615.35
Days of inventory on hand
00000
Receivables turnover
1.671.551.551.521.3
Payables turnover
4.494.545.165.435.86
Inventory turnover
00000
ROE
0.060.110.050.050.01
Capex per share
-0.01-0.02-0.01-0.01-0.02

DCGO Frequently Asked Questions

What is DocGo Inc. stock symbol ?

DocGo Inc. is a US stock , located in New york of Ny and trading under the symbol DCGO

Is DocGo Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $11. The lowest prediction is $11 and the highest is $11

What is DCGO stock prediction ?

What is DocGo Inc. stock quote today ?

DocGo Inc. stock price is $6.65 today.

Is DocGo Inc. stock public?

Yes, DocGo Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap